<div>This month, we spoke with expert Adi Zuloff-Shani, PhD, CEO of Clearmind Medicine, to hear about the new frontier of mental health treatments: psychedelic medicines. Clearmind is developing a novel treatment for addiction, which Zuloff-Shani said is part of a larger shift in approaches to mental health treatments.<br>
<br>
Interested in learning more? Check out this related content:</div>
<ul>
<li><a href="https://www.pharmacytimes.com/view/study-demonstrates-mechanism-of-psychedelic-induced-neuroplasticity">Study Demonstrates Mechanism of Psychedelic-Induced Neuroplasticity</a></li>
<li><a href="https://www.pharmacytimes.com/view/expert-blinding-in-clinical-trials-investigating-psychedelic-medicine-remains-difficult-potentially-impacting-results">Expert: Blinding in Clinical Trials Investigating Psychedelic Medicine Remains Difficult, Potentially Impacting Results</a></li>
<li><a href="https://www.pharmacytimes.com/view/psychedelic-medicine-may-offer-a-better-solution-to-overcoming-alcoholism">Psychedelic Medicine May Offer a Better Solution to Overcoming Alcoholism</a></li>
</ul>

S1 Ep195: Public Health Matters - What is Public Health?

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy. Winner of the 2021 Digital Health Media/Publications Audio Merit Award. 